Opinion

Video

Considerations for 1L Doublet and Triplet Therapy with Venetoclax in CLL

Experts on chronic lymphocytic leukemia detail how clinical trial data on doublet therapies help inform treatment decisions in the first line.

Related Videos
A panel of 3 experts on CLL
A panel of 3 experts on CLL
Moritz Fürstenau, MD
2 KOLs are featured in this program.
2 KOLs are featured in this program.
2 KOLs are featured in this series
2 KOLs are featured in this series
Mazyar Shadman, MD, MPH
2 KOLs are featured in this series
3 KOLs are featured in this series.